“…It binds to Flt4/VEGF receptor 3 (VEGFR3), a receptor tyrosine kinase that is expressed in lymphatic endothelial cells (Joukov et al, 1996), certain non-endothelial cells such as osteoblasts (Orlandini et al, 2006) and many cancer cell types (Strizzi et al, 2001;Jackson et al, 2002;Su et al, 2006;Timoshenko et al, 2007). With significantly lower affinity VEGF-C interacts with VEGFR2, which is primarily involved in the induction of hemangiogenesis (Skobe et al, 1999;Shibuya and Claesson-Welsh, 2006) and coreceptors, including the neuropilin-2 expressed on veins and lymphatic vessels (Karkkainen et al, 2001;Karpanen et al, 2006;Xu et al, 2010).…”